Gastroenterology

Standard of Care: Treating the Causes and Deficiencies

At a Glance

Treatment for chronic atrophic gastritis focuses on eliminating H. pylori when present, replacing vitamin B12 and iron deficiencies, and monitoring for Type 1 neuroendocrine tumors. In autoimmune gastritis, B12 replacement is often lifelong.

Managing chronic atrophic gastritis (CAG) is about more than just monitoring your stomach lining—it is about restoring your body’s ability to function. Because your stomach can no longer process essential nutrients, standard treatment focuses on removing triggers and bypassing the damaged “machinery” to replace what you are missing ^[1]^[2]. There is no proven diet that reverses gland loss, and you should not undertake restrictive diets or stop acid suppression on your own.

Step 1: Removing the Trigger (H. pylori)

If your biopsy shows the presence of H. pylori bacteria, treating it is the first priority. This bacteria causes the inflammation that leads to atrophy.

The Treatment Regimen: Current regimens vary with local antibiotic resistance, prior antibiotic exposure, allergies, and the regimen selected. It is not one fixed protocol; most guidelines recommend a full course of multiple antibiotics and acid-blockers directed by your clinician ^[3]^[4].
Confirming the Cure: It is critical to confirm that the bacteria are actually gone. You must wait at least 4 weeks after finishing antibiotics and an appropriate period off acid-blockers (as directed by your clinician) and then have a urea breath test or a stool antigen test ^[5]. Note: A blood test cannot confirm the infection is gone, and testing while on acid-blockers can cause false-negative results.
Residual Risk: While clearing the infection can help the stomach lining heal, it does not always completely eliminate the risk of future changes if advanced atrophy is already present. This is why continued monitoring is still necessary ^[6]^[7].

Step 2: Replacing Vitamin B12

In autoimmune gastritis (AMAG), your stomach lacks intrinsic factor, a “key” needed to unlock B12 from your food. Without this key, normal digestion of B12 is impossible.

The Injection Route: For many, a reliable treatment is intramuscular (IM) injections. These bypass the stomach entirely and deliver the vitamin directly into the muscle. The dose and schedule depend on the formulation, country, severity, and neurologic findings, and must be prescribed and monitored by your clinician ^[8].
High-Dose Oral: Some patients can absorb B12 through “passive diffusion” if the dose is high enough (typically 1,000 to 2,000 mcg daily). However, this requires very strict adherence and regular blood tests to ensure levels are actually rising ^[2]^[9]. Neurologic symptoms should not wait for a routine follow-up.
Lifelong Support: Because the cellular damage in the stomach is usually permanent, B12 replacement is typically a lifelong commitment. Stopping treatment can lead to a return of severe neurological symptoms ^[10]^[11].

Step 3: Managing Iron Deficiency

Achlorhydria (lack of stomach acid) makes it very difficult for your body to dissolve and absorb iron from food or standard pills. However, iron deficiency anemia can also reflect gastrointestinal blood loss or other issues, so the underlying source needs evaluation.

Oral Iron Trials: Your doctor may start with an oral iron supplement, sometimes taken every other day to reduce side effects like constipation ^[12].
IV Iron Infusions: If oral iron fails to raise your ferritin (stored iron), causes severe stomach pain, or if ongoing losses exist, intravenous (IV) iron may be selected based on severity and tolerance. These infusions deliver iron directly into the bloodstream, bypassing the stomach completely ^[12]^[13].

Step 4: Addressing Type 1 Neuroendocrine Tumors (NETs)

If your high gastrin levels have caused small tumors (Type 1 NETs) to form, the management depends heavily on exact size, number, grade, depth of invasion, recurrence, and other pathology.

Specialist Assessment: While some lesions are safely removed during a routine endoscopy (a process called endoscopic resection) ^[14]^[15], larger or higher-risk lesions require specialist-directed management ^[16]^[17].
Medications: If tumors frequently return or are difficult to manage, specialized medications called somatostatin analogues may be used ^[18].

Monitoring Box: Your care team may monitor your CBC, ferritin/iron indices, B12 (with appropriate confirmatory testing when needed), and thyroid function. Note that MMA interpretation is affected by kidney disease and that serum B12 can be misleading after supplementation. Successfully managing these deficiencies often leads to an improvement in energy, mental clarity, and physical strength ^[19]^[20].

Common questions in this guide

How do doctors confirm that H. pylori treatment worked in chronic atrophic gastritis?

After treatment, cure is checked with a urea breath test or stool antigen test, not a blood test. Testing is usually done at least four weeks after antibiotics and after stopping acid-suppressing medicines for the time your clinician recommends, because these medicines can cause a false-negative result.

Will I need lifelong vitamin B12 treatment for autoimmune gastritis?

Autoimmune gastritis can reduce intrinsic factor, which the body needs to absorb B12 from food. B12 may be given by injection or as high-dose oral tablets, and replacement is often lifelong with regular blood-test monitoring; follow your clinician's prescribed schedule.

When is IV iron used for chronic atrophic gastritis?

Doctors may first try oral iron, sometimes every other day to reduce constipation. IV iron may be considered when oral iron does not improve ferritin, causes severe stomach symptoms, or cannot keep up with ongoing iron loss; the cause of blood loss also needs evaluation.

How are Type 1 neuroendocrine tumors managed with chronic atrophic gastritis?

Management depends on the tumors' size, number, grade, depth of invasion, and whether they return. Some small or lower-risk lesions can be removed during endoscopy, while higher-risk or recurrent tumors may need specialist care and sometimes somatostatin analogue medication.

Which blood tests are monitored during treatment for chronic atrophic gastritis?

Monitoring may include a complete blood count, ferritin and other iron measures, vitamin B12, thyroid function, and sometimes gastrin. Kidney disease can affect some B12 confirmation tests, and serum B12 may be difficult to interpret after supplementation.

Get notified when new evidence is published on chronic atrophic gastritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (20)

1
Autoimmune Atrophic Gastritis: A Clinical Review.
Castellana C, Eusebi LH, Dajti E, et al.
Cancers 2024; (16(7)) doi:10.3390/cancers16071310.
PMID: 38610988
2
Vitamin B12 Deficiency: Recognition and Management.
Langan RC, Goodbred AJ
American family physician 2017; (96(6)):384-389.
PMID: 28925645
3
Management of Helicobacter pylori infection.
Aumpan N, Mahachai V, Vilaichone RK
JGH open : an open access journal of gastroenterology and hepatology 2023; (7(1)):3-15 doi:10.1002/jgh3.12843.
PMID: 36660052
4
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
Fallone CA, Chiba N, van Zanten SV, et al.
Gastroenterology 2016; (151(1)):51-69.e14.
PMID: 27102658
5
Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study.
Kiattiweerasak A, Aumpan N, Chonprasertsuk S, et al.
Frontiers in gastroenterology (Lausanne, Switzerland) 2023; (2()):1245993 doi:10.3389/fgstr.2023.1245993.
PMID: 41821821
6
Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
Khan MY, Aslam A, Mihali AB, et al.
European journal of gastroenterology & hepatology 2020; (32(6)):686-694 doi:10.1097/MEG.0000000000001740.
PMID: 32355093
7
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.
Liou JM, Malfertheiner P, Lee YC, et al.
Gut 2020; (69(12)):2093-2112 doi:10.1136/gutjnl-2020-322368.
PMID: 33004546
8
Intramuscular Cyanocobalamin Treatment in Patients with Corpus Atrophic Gastritis and Vitamin B12 Deficiency: Efficacy and Predictors of Increased Requirement-A Monocentric Longitudinal Real-Life Cohort Study.
Schiavone FP, Pivetta G, Scalamonti S, et al.
Nutrients 2026; (18(2)) doi:10.3390/nu18020271.
PMID: 41599884
9
Oral vitamin B12 supplementation in pernicious anemia: a prospective cohort study.
Lacombe V, Vinatier E, Roquin G, et al.
The American journal of clinical nutrition 2024; (120(1)):217-224 doi:10.1016/j.ajcnut.2024.05.019.
PMID: 38797248
10
Vitamin B12 deficiency in the elderly: is it worth screening?
Wong CW
Hong Kong medical journal = Xianggang yi xue za zhi 2015; (21(2)):155-64 doi:10.12809/hkmj144383.
PMID: 25756278
11
Pernicious anemia is a common cause of cobalamin deficiency-caused megaloblastic anemia in Hainan, China.
Shen M, Luo X, Wu C, et al.
Hematology (Amsterdam, Netherlands) 2024; (29(1)):2399375 doi:10.1080/16078454.2024.2399375.
PMID: 39248712
12
AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review.
DeLoughery TG, Jackson CS, Ko CW, Rockey DC
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(8)):1575-1583 doi:10.1016/j.cgh.2024.03.046.
PMID: 38864796
13
Iron deficiency in pernicious anemia: Specific features of iron deficient patients and preliminary data on response to iron supplementation.
Rogez J, Urbanski G, Vinatier E, et al.
Clinical nutrition (Edinburgh, Scotland) 2024; (43(4)):1025-1032 doi:10.1016/j.clnu.2024.03.011.
PMID: 38527394
14
Selective Resection of Type 1 Gastric Neuroendocrine Neoplasms and the Risk of Progression in an Endoscopic Surveillance Programme.
Chin JL, O'Connell J, Muldoon C, et al.
Digestive surgery 2021; (38(1)):38-45 doi:10.1159/000510962.
PMID: 33260173
15
The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm.
Dell'Unto E, Mandair D, Riding G, et al.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2026; (58(1)):119-124 doi:10.1016/j.dld.2025.09.011.
PMID: 41016874
16
Breaking the Size Barrier: Endoscopic Submucosal Dissection of a Massive Flat Gastric Neuroendocrine Tumor.
Tagliamonte G, Giunta M, Ravizza D, et al.
ACG case reports journal 2026; (13(7)):e02228 doi:10.14309/crj.0000000000002228.
PMID: 42428589
17
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.
Shah SC, Piazuelo MB, Kuipers EJ, Li D
Gastroenterology 2021; (161(4)):1325-1332.e7 doi:10.1053/j.gastro.2021.06.078.
PMID: 34454714
18
Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis.
Rossi RE, Invernizzi P, Mazzaferro V, Massironi S
United European gastroenterology journal 2020; (8(2)):140-147 doi:10.1177/2050640619890465.
PMID: 32213066
19
Chronic Atrophic Gastritis Presenting as Hemolytic Anemia due to Severe Vitamin B12 Deficiency.
Woodford AM, Chaudhry R, Conte GA, et al.
Case reports in hematology 2021; (2021()):9571072 doi:10.1155/2021/9571072.
PMID: 34373795
20
Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency.
Esposito G, Dottori L, Pivetta G, et al.
Nutrients 2022; (14(8)) doi:10.3390/nu14081672.
PMID: 35458234

This page is for informational purposes only and does not constitute medical advice. Your clinician should tailor H. pylori treatment, B12 and iron replacement, and tumor monitoring to your results.